Diagnostic and therapeutic difficulties in neurocysticercosis: Presentation of 6 cases and review of the literature;Dificultades diagnósticas y terapéuticas en la neurocisticercosis: Presentacion de 6 casos y revisión de la literatura

Neurocirugia

Volumn 18, Issue 2, 2007, Pages 101-110

  Ensenat J ^a   Martínez Mañas, Rosa ^a,b   Horcajada, J P ^a   De Juan, C ^a   Ferrer, E ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Hopital de Sion   (Switzerland)

Author keywords

Antiparisitic drugs; EITB; ELISA; Neurocysticercosis; Surgery

Indexed keywords

ANTIPARASITIC AGENT; STEROID;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; NEUROCYSTICERCOSIS; NEUROIMAGING; NEUROLOGIC DISEASE; PALLIATIVE THERAPY; PRACTICE GUIDELINE;

EID: 34249313700     PISSN: 11301473     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1473(07)70294-4     Document Type: Article

References (43)

1. Abraham, R., Pardini, A.X., Vaz, A.D., Livramento, J.A., Machado dos Ramos, L.: Taenia antigens detection in the cerebrospinal fluid of patients with neurocysticercosis and its relationship with clinical activity of the disease. Arq Neuropsyquiatr. 2004; 62 (3B): 756-760.
2. Agapejev, S., Silva, M.D., Ueda, A.K.: Severe forms of neurocysticercosis. Treatment with albendazole. Arq Neuropsyquatr. 1996; 54: 82-93.
3. Bergsneide, M.: Endoscopic removal of cysticercal cysts within the fourth ventricle. Technical note. J Neurosurg. 1999; 91: 340-345.
4. Bergsneider, M., Holly, T.H., Lee, J.H., King, W.A., Frazee, J.G.: Endoscopic management of cysticercal cysts within the lateral and third ventricles. J Neurosurg. 2000; 92: 14-23.
5. Carpio, A., Hauser, W.A.: Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology. 2002; 59: 1730-1734.
6. Castro, N., Medina, R., Sotelo, J., Jung, H.: Bioavailability of praziquantel increases with concomitant administration of food. Antimicrob Agents Chemother. 2000; 44: 2903-2904.
7. Castro, N., Jung, H., Medina, R., González-Esquivel, D., López, M., Sotelo, J.: Interaction between grapefruit juice and praziquantel in humans. Antimicrob Agents Chemother. 2002; 46: 1614-1616.
8. Cho, S.Y., Kim, S.I., Kang, S.Y.: Serologic follow-up study in neurocysticercosis patients by ELISA after praziquantel therapy. Kisaengchunghak Chapchi. 1986; 24: 159-170.
9. Cho, S.Y., Kim, S.I., Kang, S.Y., Park, A.J.: Intracranial synthesis of specific IgG antibody in cerebrospinal fluid of neurocysticercosis patients. Kisaengchunghak Chapchi. 1988; 26: 15-26.
10. Colli, B.O., Martelli, N., Assirati, J.A. Jr, Machado, H.R., de Vergueiro Forjaz, S.: Results of surgical treatment of neurocysticercosis in 69 cases. J. Neurosurg. 1986; 65: 309-315.
11. Colli, B.O., Martelli, N., Assirati, J.A., et al.: Cysticercosis of the central nervous system. Surgical tratment of cerebral cysticercosis: a 23-year experience in the Hospital das Clinicas of Ribeirao Preto Medical School. Arq Neuropsyquatr. 1994; 52: 166-186.
12. Del Brutto, O.H., Sotelo, J., Roman, G.C.: Neurocysticercosis. A clinical handbook. Swets & Zeitlinger publishers. Lisse. The Netherlands, 1998. Pp 216.
13. Del Brutto, O.H., Santibáñez, R., Idovro, L., et al.: Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia. 2005; 46: 583-587.
14. Esquivel, A., Díaz-Otero, F., Giménez-Roldán, S.: Growing frequency of neurocysticercosis in Madrid (Spain). Neurología. 2005; 20: 116-120.
15. Flisser, A., Gauci, C.G., Zoli, A., et al.: Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun. 2004; 72: 5292-5297.
16. García, H.H., Gilman, R.H., Catacora, M., Verastegui, M., González, A.E., Tsang, V.C.: Serologic evolution of neurocysticercosis patients after antiparasitic therapy. J Infect Dis. 1997; 175: 486-489.
17. García, H.H., Evans, C.A.W., Nash, T.E., et al.: Current consensus guidelines for treatment of neurocysticercosis. Clinical Microbiol Rev. 2002; 15: 747-756.
18. González, A.E., Gauci, C.G., Barber, D., et al.: Vaccination of pigs to control human neurocysticercosis. A, J Trop Med Hyg. 2005; 72: 837-839.
19. Hawk, M.W., Shahlaie, K., Kim, K.D., Theis, J.H.: Neurocysticercosis: a review. Surg Neurol. 2005; 63: 123-132
20. Jung, H., Medina, R., Castro, N., Corona, T., Sotelo, J.: Pharmacokinetic of study of praziquantel alone and in combination with cimetidine in a single-day therapeutic regimen. Antimicrob Agents Chemother. 1997; 41: 1256-1259.
21. Kim, I.Y., Kim, T.S., Lee, J.H., Lee, J.K., Jung, S.: Inflammatory aneurysm due to neurocysticercosis. J Clin Neurosc. 2005; 12: 585-588.
22. Lanchote, V.L., García, F.S., Dreossi, S.A., Takayanagui, OM.: Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Thar Drug Monit. 2002; 24: 338-345.
23. Lightowlers, M.W.: Vaccines for prevention of cysticercosis. Acta Trop. 2003; 87:129-135.
24. Lightowlers, M.W.: Vaccination for the prevention of cysticercosis. Dev Biol. 2004; 119: 361-368.
25. López-Gómez, M., Castro, N., Jung, H., Sotelo, J., Corona, T.: Optimization of the single-day praziquantel therapy for neurocysticercosis. Neurology. 2001; 57: 1929-1930.
26. Madrazo, I., Proaño, J.V.: Tratamiento quirúrgico de la neurocisticercosis. In: Arriagada C, Nogales-Gaete J, Apt W, eds. Neurocisticercosis. Santiago, Chile: Arryong. 1997; pp. 229-231.
27. Marques, M.P.C., Takayanagui, O.M., Bonato, P.S., Santos, S.R.C.J., Lanchote, V.L.: Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis. Chirality. 1999; 11: 218-223.
28. Marques, M.P., Takayanagui, O.M., Lanchote, V.L.: Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome p450. Braz J Med Biol Res. 2002; 35: 261-269.
29. Mirfazaelian, A., Dadashzadeh, S., Rouini, M.R.: Effect of gender in the disposition of albendazole metabolites in humans. Eur J Clin Pharmacol. 2002; 58: 403-408.
30. Obrador, S.: Cysticercosis cerebri. Acta Neurochir. 1962; 10: 320-364.
31. Odashima, N.S., Takayanagui, O.M., de Castro Figuereido, J.F.: Enzyme linked immunosorbent assay (ELISA) for the detection of IgG, IgM, IgE and IgA against cysticercus cellulosae in cerebrospinal fluid of patients with neurocysticercosis. Arq Neuropsyquiatr. 2002; 60 (2B): 400-405.
32. Proaño, J.V., Madrazo, I., Avelar, F., López-Félix, B., Díaz, G., Grijalva, I.: Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med. 2001; 345: 879-885.
33. Richards, F., Jr, Schartz, P.M.: Laboratory diagnosis of cysticercosis. Clin Lab Med. 1991; 11:1011-1028.
34. Riley, T., White, A,C.: Management of neurocysticercosis. CNS Drugs. 2003; 17: 577-591.
35. Roca, C., Gascón, J., Font, B., Pujol, T., Valls, M.E., Corachán, M.: Neurocysticercosis and population movements: analysis of 23 imported cases in Spain. Eur J Clin Microbiol Infect Dis. 2003; 22: 382-384.
36. Roman, G.C.: Neurocysticercosis. A public health perspective. Rev Neurol. 2003; 36: 71-74.
37. Sazon, F., Osorio, A.M., Morales, J.P.: Serological screening for cysticercosis in mentally altered individuals. Trop Med Int Health. 2002; 7: 532-538.
38. Schipper, H.G., Koopmans, R.P., Nagy, J., Butter, J.J., Kager, P.A., Van Boxtel, C.J.: Effect of dose increase of cimetidine coadministration on albendazole bioavailability. Am J Trop Med Hyg. 2000; 63: 270-273.
39. Sotelo, J., Jung, H.: Pharmacokinetic optimization of the treatment of neurocysticercosis. Pharmacokinet, 1998; 34: 503-515.
40. Takayanagui, O.M., Lanchote, J.L., Marques, M.P.C., Bonato, P.S.: Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone. Ther Drug Monit. 1997; 19: 51-55.
41. Takayanagui, O.M.: Therapy for neurocysticercosis. Expert. Rev Neurother. 2004; 4: 129-139.
42. Wallin, M.T., Kurtzke, J.F.: Neurocysticercosis in the United States: review of an important emerging infection. Neurology. 2004: 63: 1559-1564.
43. Wilson, M., Bryan, R.T., Fried, J.A., et al.: Clinical evaluation of cysticercosis enzyme-linked inmunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis. 1991;164:1007-1009.